Search research articles
Contact Us
Filters
Showing results (361-370 of 667) with videos related to
Page
of 67
Sort By:
Cell Reports
|
April 27, 2017
Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation
Tongqing Zhou, Nicole A Doria-Rose, Cheng Cheng, et al.
The New England Journal of Medicine
|
December 14, 2016
Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption
Katharine J Bar, Michael C Sneller, Linda J Harrison, et al.
The Journal of Experimental Medicine
|
August 18, 2025
Structural and genetic basis of HIV-1 envelope V2 apex recognition by rhesus broadly neutralizing antibodies
Ryan S Roark, Rumi Habib, Jason Gorman, et al.
Biorxiv : the Preprint Server for Biology
|
September 5, 2025
Profiling a large HIV-1 elite neutralizer cohort reveals remarkable CD4bs bNAb for HIV-1 prevention and therapy
Lutz Gieselmann, Andrew T DeLaitsch, Malena Rohde, et al.
Eclinicalmedicine
|
July 5, 2022
Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: A first-in-human open-label, randomized, dose-escalation, phase 1 clinical trial
Katherine V Houser, Martin R Gaudinski, Myra Happe, et al.
The New England Journal of Medicine
|
January 26, 2022
SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination
Rolando Pajon, Nicole A Doria-Rose, Xiaoying Shen, et al.
Nature Immunology
|
October 6, 2025
Profiling of HIV-1 elite neutralizer cohort reveals a CD4bs bnAb for HIV-1 prevention and therapy
Lutz Gieselmann, Andrew T DeLaitsch, Malena Rohde, et al.
Nature Medicine
|
April 12, 2022
Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial
Joseph P Casazza, Evan M Cale, Sandeep Narpala, et al.
Biorxiv : the Preprint Server for Biology
|
March 3, 2021
Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants
Lingshu Wang, Tongqing Zhou, Yi Zhang, et al.
Biorxiv : the Preprint Server for Biology
|
November 19, 2025
Vaccine Elicitation of HIV-1 Neutralizing Antibodies Against Both V2 Apex and Fusion Peptide in Rhesus Macaques
Hongying Duan, Joseph P Nkolola, Shuishu Wang, et al.
Page
of 67
Search research articles
Search
Showing results (361-370 of 667) with videos related to
Sort By:
Page
of 67
Cell Reports
|
April 27, 2017
Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation
Tongqing Zhou, Nicole A Doria-Rose, Cheng Cheng, et al.
The New England Journal of Medicine
|
December 14, 2016
Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption
Katharine J Bar, Michael C Sneller, Linda J Harrison, et al.
The Journal of Experimental Medicine
|
August 18, 2025
Structural and genetic basis of HIV-1 envelope V2 apex recognition by rhesus broadly neutralizing antibodies
Ryan S Roark, Rumi Habib, Jason Gorman, et al.
Biorxiv : the Preprint Server for Biology
|
September 5, 2025
Profiling a large HIV-1 elite neutralizer cohort reveals remarkable CD4bs bNAb for HIV-1 prevention and therapy
Lutz Gieselmann, Andrew T DeLaitsch, Malena Rohde, et al.
Eclinicalmedicine
|
July 5, 2022
Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: A first-in-human open-label, randomized, dose-escalation, phase 1 clinical trial
Katherine V Houser, Martin R Gaudinski, Myra Happe, et al.
The New England Journal of Medicine
|
January 26, 2022
SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination
Rolando Pajon, Nicole A Doria-Rose, Xiaoying Shen, et al.
Nature Immunology
|
October 6, 2025
Profiling of HIV-1 elite neutralizer cohort reveals a CD4bs bnAb for HIV-1 prevention and therapy
Lutz Gieselmann, Andrew T DeLaitsch, Malena Rohde, et al.
Nature Medicine
|
April 12, 2022
Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial
Joseph P Casazza, Evan M Cale, Sandeep Narpala, et al.
Biorxiv : the Preprint Server for Biology
|
March 3, 2021
Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants
Lingshu Wang, Tongqing Zhou, Yi Zhang, et al.
Biorxiv : the Preprint Server for Biology
|
November 19, 2025
Vaccine Elicitation of HIV-1 Neutralizing Antibodies Against Both V2 Apex and Fusion Peptide in Rhesus Macaques
Hongying Duan, Joseph P Nkolola, Shuishu Wang, et al.
Page
of 67